Meeting Overview - The seventh meeting of the fifth Supervisory Board of Sanofi Health (Shanghai) Co., Ltd. was held on August 29, 2025, with all procedures complying with relevant laws and regulations [1] Resolutions Passed - The Supervisory Board unanimously approved the proposal to abolish the Supervisory Board and amend the Articles of Association, transferring its powers to the Audit Committee of the Board of Directors [1] - The Supervisory Board approved the 2025 semi-annual report and summary, confirming compliance with legal and internal regulations, and ensuring the accuracy and completeness of the disclosed information [2] - The Supervisory Board approved the mid-term profit distribution plan for 2025, which considers the company's operational status and future funding needs, and agreed to submit it for shareholder meeting approval [3] - The Supervisory Board approved a special report on the management and actual use of raised funds for the first half of 2025, confirming compliance with relevant regulations [4] - The Supervisory Board approved the proposal to permanently supplement working capital with surplus raised funds from completed projects, emphasizing the efficient use of funds and alignment with the company's operational plans [5]

Core Viewpoint - Sangfor Health has decided to abolish its supervisory board and amend its articles of association to enhance corporate governance in compliance with the latest legal regulations [1][2]. Group 1: Corporate Governance Changes - The company will no longer have a supervisory board, and its powers will be transferred to the audit committee of the board of directors [1]. - The relevant rules associated with the supervisory board will be abolished, including the "Rules of Procedure for the Supervisory Board" [1]. - Amendments to the articles of association will be made to align with the new governance structure and legal requirements [1][2]. Group 2: Legal Compliance - The changes are in accordance with the revised Company Law of the People's Republic of China (2023) and the Guidelines for Articles of Association of Listed Companies (2025) [1][2]. - The company aims to protect the legitimate rights and interests of shareholders and creditors while standardizing its organizational behavior [1][2]. Group 3: Responsibilities and Rights - The articles of association will define the responsibilities of the legal representative and the rights of shareholders, ensuring that all actions taken by the legal representative are binding on the company [4][5]. - Shareholders will retain the right to sue the company and its directors, supervisors, and senior management under the new governance framework [5][10].

Meeting Details - The fourth meeting of the Supervisory Board of Mingguan New Materials Co., Ltd. was held on August 29, 2025, combining on-site and remote voting methods [1] - The meeting was attended by all three supervisors, and the notice was sent on August 23, 2025, via email [1] Resolution Summary - The Supervisory Board unanimously approved the proposal to cancel the Supervisory Board, amend the Articles of Association, and proceed with the necessary business registration changes [1] - Following the cancellation of the Supervisory Board, the roles of supervisors and the chairman of the Supervisory Board will also be terminated, with the Audit Committee of the Board of Directors assuming the powers previously held by the Supervisory Board [1] - The proposal is subject to approval by the company's shareholders' meeting, with a voting result of 3 votes in favor, 0 against, and 0 abstentions [2]

Core Points - The company held its fifth board meeting on August 28, 2025, to discuss and approve several key proposals [1] - The board approved the 2025 semi-annual report and its summary, which can be found on the Shanghai Stock Exchange website [1] - The board also approved a special report on the storage and actual use of raised funds for the first half of 2025, with all votes in favor [2] - The company revised and established several corporate governance systems to enhance operational standards and internal management mechanisms [2][4] Summary by Categories - **Meeting Details** - The meeting was chaired by Chairwoman Yu Yajun and attended by all seven voting directors [1] - The meeting's procedures complied with relevant laws and regulations [1] - **Financial Reports** - The board approved the 2025 semi-annual report and its summary [1] - A special report on the use of raised funds was also approved [2] - **Corporate Governance** - The company undertook a comprehensive review of its internal governance systems [2] - Several governance documents were revised and new systems were established, effective immediately upon board approval [4]

Core Viewpoint - Shanghai Mingzhi Electric Co., Ltd. has held its sixth meeting of the fifth board of directors, where several important resolutions were passed regarding the company's governance and operational structure [1]. Group 1: Financial Reporting - The board approved the 2025 semi-annual report, affirming that it accurately reflects the company's operational and financial status without any false statements or omissions [1]. Group 2: Governance Changes - The board agreed to abolish the supervisory board, transferring its responsibilities to the audit committee of the board, and corresponding amendments to the company's articles of association were approved [2]. - The board passed resolutions to revise the rules for shareholder meetings, board meetings, and specialized committee meetings, which will also be submitted for shareholder approval [3][4][5]. Group 3: Management and Internal Controls - Multiple internal management systems were revised, including the independent director work system, president work guidelines, and information disclosure management system [4][5][6]. - The company also approved revisions to the major investment and transaction decision-making system, external guarantee management system, and related party transaction decision-making system [6][7][8]. Group 4: Upcoming Events - The company plans to hold its second extraordinary general meeting of 2025 on September 26, 2025, combining on-site and online voting [10].

Group 1 - The company held its second board meeting on August 18, 2025, with all 7 directors present, and the meeting complied with legal and regulatory requirements [1] - The board approved the 2025 semi-annual report and the special report on the use of raised funds, with unanimous support [2] - The board agreed to increase the foreign exchange derivative trading limit by up to 200 million RMB, which can be reused within the authorized period [2] Group 2 - The company plans to change its registered address and increase the board size from 7 to 8 members by adding a staff representative director, while abolishing the supervisory board [3] - Various governance documents and rules were revised and approved unanimously, including the rules for shareholder meetings and board meetings [4][5] - The board proposed to hold the second extraordinary general meeting of shareholders in September 2025 [6]

Group 1 - The company will hold its first extraordinary general meeting of shareholders in 2025, allowing for both network and internet voting during specified time slots on the day of the meeting [2] - The meeting will take place at the company's conference room located at 2388 Chenxing Road, Minhang District, Shanghai [4] Group 2 - Proposal one involves the cancellation of the supervisory board and the revision of the company's articles of association, in compliance with the new Company Law effective from July 1, 2024 [3] - The supervisory board will be replaced by the audit committee of the board of directors, which will assume the supervisory responsibilities as per the Company Law [3] - The company will also systematically revise its articles of association to align with the latest legal regulations and protect the rights of stakeholders [3][4] Group 3 - Proposal two focuses on the formulation and revision of certain corporate governance systems to enhance operational standards and protect investor rights [5] - The company has reviewed and updated its governance systems in accordance with relevant laws and regulations [5]

Core Points - The company held its 18th meeting of the 5th Board of Directors on August 26, 2025, where all 7 directors were present and the meeting was chaired by Chairman Liu Zili [1] - The Board approved the 2025 semi-annual report and summary, which was reviewed by the Audit Committee [1] - The Board agreed to abolish the Supervisory Board and amend the Articles of Association and related rules, with the Audit Committee taking over the supervisory responsibilities [1] Governance Revisions - The Board approved a series of amendments to the company's governance systems based on current laws and regulations, with all proposals receiving unanimous support from the directors [2][3][4] - Specific amendments included revisions to the Audit Committee's working rules, external investment management system, fundraising usage management measures, investor relations management system, and information disclosure management system [2][3][4] - Additional governance revisions included updates to internal control systems, financial management systems, and management of related party transactions [3][4] Shareholder Meeting - The Board approved a proposal to convene the company's first extraordinary general meeting of 2025, which will require shareholder approval for certain governance amendments [4]

Core Viewpoint - The board of directors of Guangdong Yidun Electronics Technology Co., Ltd. held its 18th meeting of the 6th session, where several important resolutions were passed regarding the company's operations and governance structure [1][2][3]. Board Meeting Details - The board meeting was conducted in compliance with relevant laws and regulations, with all 9 directors present either in person or via telecommunication [1]. - The meeting was chaired by the company's chairman, and all executive members and supervisors attended [1]. Resolutions Passed - The board approved the 2025 semi-annual report, confirming its accuracy and compliance with legal requirements, with a unanimous vote of 9 in favor [2]. - A proposal for external donations not exceeding 500,000 RMB for educational development was approved, also with a unanimous vote [2]. - The board agreed to reappoint the accounting firm, with details to be disclosed on the Shanghai Stock Exchange [2]. - A significant resolution was passed to amend the company's articles of association, eliminating the supervisory board and transferring its responsibilities to the audit committee of the board [3]. - Several governance documents, including the rules for shareholder meetings and board meetings, were revised and approved unanimously [4][5]. Upcoming Actions - The board has scheduled the first extraordinary general meeting of 2025 for September 23, 2025, to discuss the resolutions that require shareholder approval [5].

Meeting Overview - The ninth board meeting of Guizhou Xibang Pharmaceutical Co., Ltd. was held on August 28, 2025, in a combined onsite and remote format, with all 8 directors present [1] - The meeting was legally convened and conducted in accordance with relevant laws and regulations [1] Resolutions Passed - The board unanimously approved the profit distribution plan for the first half of 2025, considering the company's profitability and overall financial status [2] - The proposal to amend relevant provisions of the company's articles of association was also approved [2][3] - The company plans to abolish the supervisory board, transferring its responsibilities to the audit committee of the board, pending approval from the shareholders' meeting [3] - Several governance system revisions were approved to enhance operational standards and governance effectiveness [4] Future Actions - All resolutions, including the profit distribution plan and governance amendments, are subject to approval at the company's first extraordinary general meeting of 2025 [2][3][4] - The company has announced the convening of the first extraordinary general meeting of 2025 [4][6]